FDA Approved: TICAGRELOR — Original Application (BIONPHARMA INC.)

View source ↗

Summary

FDA approved an original application for ticagrelor from Bionpharma Inc., making a generic version of this antiplatelet medication available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

ORIG AP for TICAGRELOR (TICAGRELOR)